1. Cortes, E. P., Holland, J. F., Wang, J. J. et al.: Doxorubicin in disseminated osteosarcoma. JAMA 221, 1132–1138 (1972).
2. Cortes, E. P., Holland, J. F., Wang, J. J. et al.: Chemotherapy of advanced osteosarcoma. Colston paper No. 24. In: Bone-certain aspects of neoplasia price, CHG, Rose, F. G. M. (eds.), pp. 265–280. London: Butterworth 1972.
3. Cortes, E. P., Holland, J. F., Wang, J. J. et al.: Amputation and adriamycin in primary osteosarcoma. N. Engl. J. Med. 291, 998–1000 (1974).
4. Cortes, E. P., Holland, J. F., Wang, J. J. et al.: Adriamycin (NSC-123127) in 87 patients with osteosarcoma. Cancer Chemother. Rep. (Part 3) 6, 305–313 (1975).
5. Cortes, E. P., Lutman, G., Wanka, J. et al.: Adriamycin (NSC-123127) cardiotoxicity: a clinicopathologic correlation. Cancer Chemother. Rep. (Part 3), 6, 215–225 (1975).